Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Pharmaceutics|October 22, 2020
Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast CancerFrancisco J Cimas, Enrique Niza, Alberto Juan, et al.
Dalton Transactions (Cambridge, England : 2003)|December 24, 2014
Catalytic behaviour in the ring-opening polymerisation of organoaluminiums supported by bulky heteroscorpionate ligandsJose A Castro-Osma, Carlos Alonso-Moreno, Agustín Lara-Sánchez, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 26, 2024
Antitumoral activity of a CDK12 inhibitor in colorectal cancer through a liposomal formulationCristina Díaz-Tejeiro, María Arenas-Moreira, Adrián Sanvicente, et al.
Dalton Transactions (Cambridge, England : 2003)|March 12, 2011
Heteroscorpionate rare-earth initiators for the controlled ring-opening polymerization of cyclic estersAntonio Otero, Agustín Lara-Sánchez, Juan Fernández-Baeza, et al.
Inorganic Chemistry|February 12, 2010
Hybrid scorpionate/cyclopentadienyl magnesium and zinc complexes: synthesis, coordination chemistry, and ring-opening polymerization studies on cyclic estersAndrés Garcés, Luis F Sánchez-Barba, Carlos Alonso-Moreno, et al.
Dalton Transactions (Cambridge, England : 2003)|September 23, 2009
Synthesis, structures and ring-opening polymerization studies of new zinc chloride and amide complexes supported by amidinate heteroscorpionate ligandsLuis F Sánchez-Barba, Carlos Alonso-Moreno, Andrés Garcés, et al.
Dalton Transactions (Cambridge, England : 2003)|June 10, 2016
Tris(pentafluorophenyl)borane as an efficient catalyst in the guanylation reaction of aminesAntonio Antiñolo, Fernando Carrillo-Hermosilla, Rafael Fernández-Galán, et al.
Pharmaceutics|October 23, 2021
Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast CancerElena Domínguez-Jurado, Francisco J Cimas, José Antonio Castro-Osma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 13, 2025
Liposomal formulation of the CDK9 PROTAC THAL-SNS-032 enhances the antitumor activity in breast cancer cell linesMaría Arenas-Moreira, María Del Mar Noblejas-López, Consuelo Ripoll, et al.
Dalton Transactions (Cambridge, England : 2003)|January 13, 2010
New achiral and chiral NNE heteroscorpionate ligands. Synthesis of homoleptic lithium complexes as well as halide and alkyl scandium and yttrium complexesAntonio Otero, Agustín Lara-Sánchez, Juan Fernández-Baeza, et al.
Pageof 8